Lineagen Explained

Lineagen, Inc.
Logo Alt:Lineagen logo
Type:Private
Founders:Michael S. Paul, Andy Peiffer
Industry:Biotechnology
Products:personal genome testing
Services:Genetic testing, medical research
Foundation:March 2006
Location City:Salt Lake City, Utah
Location Country:United States

Lineagen, Inc. is a privately held personal genomics and biotechnology company based in Salt Lake City, UT. The company was incorporated in 2006 and collaborated with two leading autism research institutions: the University of Utah and The Children's Hospital of Philadelphia (CHOP), to identify novel genetic variants likely causal of autism spectrum disorder.[1] [2] [3] [4] Lineagen was granted an exclusive commercial license to these novel genetic variants. Notably, the markers from CHOP, published in Nature and PLoS Genetics, were named by TIME magazine as one of the top ten medical breakthroughs of 2009.[5] [6]

Since 2010, Lineagen provides genetic laboratory services to healthcare providers, which include fluorescence in situ hybridization (FISH), karyotyping and chromosomal microarray testing for children with childhood development disorders.[7] [8] In 2012, Lineagen and Affymetrix, Inc. announced that the companies have signed an agreement where Lineagen receives exclusive rights to develop a proprietary chromosomal microarray assay based on Affymetrix' GeneChip technology platform.[9] [10]

References

  1. Web site: Lineagen Announces Identification of 39 Genetic Variants as Novel Risk Factors for Developing Autism Spectrum Disorder (ASD). Inc.. Lineagen. www.prnewswire.com. en. 2017-02-16.
  2. News: University of Utah scientists find 24 new genetic markers for autism. Tribune. Kirsten Stewart, Heather May And Lindsay Whitehurst The Salt Lake. The Salt Lake Tribune. 2017-02-16. en-US.
  3. Web site: Lineagen Completes 9000-Person Study Focused on Genetic Variants in Individuals Diagnosed with Autism Spectrum Disorder (ASD). Lineagen. www.prnewswire.com. en. 2017-02-16.
  4. Web site: U of Utah Researchers Improve Genetic Understanding of Autism. healthcare.utah.edu. en. 2017-02-16.
  5. Web site: Lineagen Completes 9000-Person Study Focused on Genetic Variants in Individuals Diagnosed with Autism Spectrum Disorder (ASD). Lineagen. www.prnewswire.com. en. 2017-02-16.
  6. Web site: CHOP Autism Research Among Time's Top 10 Medical Breakthroughs. Philadelphia. The Children's Hospital of. 2014-08-10. www.chop.edu. en. 2017-02-16.
  7. Web site: Lineagen Launches FirstStepDx Genetic Testing and Counseling Service to Help Physicians Diagnose Autism and Developmental Delay Earlier Business Wire. www.businesswire.com. en. 2017-02-16. 2011-01-10.
  8. Web site: Lineagen, Inc. Closes $5 Million to Complete $10.8 Million Series A Round Business Wire. www.businesswire.com. en. 2017-02-16. 2010-08-30.
  9. Web site: Lineagen Applies Affymetrix' GeneChip® Technology to Next-Generation FirstStepDx® Service for Individuals with Developmental Delay and Autism Spectrum Disorders. Inc.. Lineagen. www.prnewswire.com. en. 2017-02-16.
  10. Web site: LineaGen Research Corporation Selects Affymetrix Santa Clara California Technology to Discover Genes Associated With Autism and Multiple Sclerosis. www.biospace.com. 2017-02-16.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Lineagen".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.